Over-expression of cyclin D1 regulates Cdk4 protein synthesis

Cell Proliferation

Volumn 36, Issue 6, 2003, Pages 347-360

  Parker, M A ^a   Deane, N G ^a   Thompson, E A ^b   Whitehead, R H ^a   Mithani, S K ^a   Washington, M K ^a   Datta, P K ^a   Dixon, D A ^a   Beauchamp, R D ^a,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN STABILITY; PROTEIN SYNTHESIS;

ANIMALS; CELL LINE, TRANSFORMED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANSDUCTION, GENETIC;

ANIMALIA;

EID: 0345059788     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2003.00290.x     Document Type: Article

References (36)

1. ALBRECHT JH, POON RY, AHONEN CL, RIELAND BM, DENG C, CRARY GS (1998) Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 16, 2141.
2. ALLEN KJ, REYES R, DEMMLER K, MERCER JF, WILLIAMSON R, WHITEHEAD RH (2000) Conditionally immortalized mouse hepatocytes for use in liver gene therapy. J. Gastroenterol. Hepatol. 15, 1325.
3. ARBER N, DOKI Y, HAN EK, SGAMBATO A, ZHOU P, KIM NH, DELOHERY T, KLEIN MG, HOLT PR, WEINSTEIN IB (1997) Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57, 1569.
4. BARTEK J, BARTKOVA J, LUKAS J (1996) The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805.
5. BARTKOVA J, LUKAS J, STRAUSS M, BARTEK J (1994) The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer 58, 568.
6. CHEUNG TH, YU MM, LO KW, YIM SF, CHUNG TK, WONG YF (2001) Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett. 166, 199.
7. CONNELL-CROWLEY L, HARPER JW, GOODRICH DW (1997) Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol. Cell 8, 287.
8. DEANE NG, PARKER MA, ARAMANDLA R, DIEHL L, LEE WJ, WASHINGTON MK, NANNEY LB, SHYR Y, BEAUCHAMP RD (2001) Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 61, 5389.
9. DONG Y, SUI L, SUGIMOTO K, TAI Y, TOKUDA M (2001) Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int. J. Cancer 95, 209.
10. DONNELLAN R, CHETTY R (1998) Cyclin D1 and human neoplasia. Mol. Pathol. 51, 1-7.
11. DRISCOLL B, WU L, BUCKLEY S, HALL FL, ANDERSON KD, WARBURTON D (1997) Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol. 273, L941.
12. EWEN ME, SLUSS HK, WHITEHOUSE LL, LIVINGSTON DM (1993) TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009.
13. 1 cell-cycle arrest. Genes Dev. 9, 204.
14. HANKS SK (1987) Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl Acad. Sci. USA 84, 388.
15. JIANG W, ZHANG YJ, KAHN SM, HOLLSTEIN MC, SANTELLA RM, LU SH, HARRIS CC, MONTESANO R, WEINSTEIN IB (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl Acad. Sci. USA 90, 9026.
16. KIM H, HAM EK, KIM YI, CHI JG, LEE HS, PARK SH, JUNG YM, MYUNG NK, LEE MJ, JANG JJ (1998) Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas. Cancer Lett. 131, 177.
17. KITAGAWA M, HIGASHI H, JUNG HK, SUZUKI-TAKAHASHI I, IKEDA M, TAMAI K, KATO J, SEGAWA K, YOSHIDA E, NISHIMURA S, TAYA Y (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060.
18. KITAHARA K, YASUI W, YOKOZAKI H, SEMBA S, HAMAMOTO T, HISATSUGU T, TAHARA E (1996) Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J. Exp. Ther. Oncol. 1, 7.
19. KO TC, BEAUCHAMP RD, TOWNSEND CM JR, THOMPSON EA, THOMPSON JC (1994) Transforming growth factor-β inhibits rat intestinal cell growth by regulating cell cycle specific gene expression. Am. J. Surg. 167, 14.
20. KORNMANN M, ARBER N, KORC M (1998a) Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Invest 101, 344.
21. KORNMANN M, ISHIWATA T, ITAKURA J, TANGVORANUNTAKUL P, BEGER HG, KORC M (1998b) Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology 55, 363.
22. MASCIULLO V, SCAMBIA G, MARONE M, GIANNITELLI C, FERRANDINA G, BELLACOSA A, BENEDETTI PANICI P, MANCUSO S (1997) Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int. J. Cancer 74, 390.
23. MILLER SJ, SUTHIPHONGCHAI T, ZAMBETTI GP, EWEN ME (2000) p53 binds selectively to the 5′ untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor β-and p53-mediated translational inhibition of cdk4. Mol. Cell Biol. 20, 8420.
24. MUELLER A, ODZE R, JENKINS TD, SHAHSESFAEI A, NAKAGAWA H, INOMOTO T, RUSTGI AK (1997) A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res. 57, 5542.
25. NAKAGAWA H, WANG TC, ZUKERBERG L, ODZE R, TOGAWA K, MAY GH, WILSON J, RUSTGI AK (1997) The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 14, 1185.
26. NISHIDA N, FUKUDA Y, KOMEDA T, KITA R, SANDO T, FURUKAWA M, AMENOMORI M, SHIBAGAKI I, NAKAO K, IKENAGA M et al. (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54, 3107.
27. RAMLJAK D, JONES AB, DIWAN BA, PERANTONI AO, HOCHADEL JF, ANDERSON LM (1998) Epidermal growth factor and transforming growth factor-α- associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice. Cancer Res. 58, 3590.
28. SANTONI-RUGIU E, JENSEN M, THORGEIRSSON S (1998) Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res. 58, 123.
29. SEGLEN PO (1976) Preparation of isolated rat liver cells. Meth. Cell Biol. 13, 29.
30. SHAPIRO GI, EDWARDS CD, KOBZIK L, GODLESKI J, RICHARDS W, SUGARBAKER DJ, ROLLINS BJ (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505.
31. SHERR CJ (1996) Cancer cell cycles. Science 274, 1672.
32. SIMON TC, ROTH KA, GORDON JI (1993) Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabp1) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J. Biol. Chem. 268, 18345.
33. WANG QS, PAPANIKOLAOU A, SABOURIN CL, ROSENBERG DW (1998) Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. Carcinogenesis 19, 2001.
34. ZHANG YJ, JIANG W, CHEN CJ, LEE CS, KAHN SM, SANTELLA RM, WEINSTEIN IB (1993) Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 196, 1010.
35. ZHANG T, NANNEY LB, LUONGO C, LAMPS L, HEPPNER KJ, DUBOIS RN, BEAUCHAMP RD (1997) Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res. 57, 169.
36. ZHOU P, JIANG W, ZHANG YJ, KAHN SM, SCHIEREN I, SANTELLA RM, WEINSTEIN IB (1995) Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11, 571.